Adage Capital Partners Gp, L.L.C. Bridge Bio Pharma, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51.6 Billion
- Q1 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 516,555 shares of BBIO stock, worth $19.4 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
516,555
Previous 270,000
91.32%
Holding current value
$19.4 Million
Previous $7.41 Million
141.05%
% of portfolio
0.03%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding BBIO
# of Institutions
362Shares Held
185MCall Options Held
12.8MPut Options Held
2.09M-
Viking Global Investors LP22.1MShares$828 Million2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$723 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$559 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$467 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$269 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.56B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...